| Bioabsorbable Everolimus-Eluting Stents for Internal Pudendal Artery-Related Arteriogenic Erectile Dysfunction (NCT02492386) | National Taiwan University Hospital | 2015-07-01 |
| Apatinib as Maintenance Therapy After First-line Chemotherapy(DC for 4 Cycles) in Postoperative Recurrence/Metastasis Progressive Gastric Cancer (NCT02509806) | Hebei Medical University | 2015-07-01 |
| Effects of Subcutaneous Hyaluronidase Administration on Psoriatic Plaques (NCT01987609) | Tissa Hata, MD | 2015-07-01 |
| Dose-ranging Study in Patients With Type 1 Diabetes Mellitus (NCT02459899) | Lexicon Pharmaceuticals | 2015-07-01 |
| Fecal Microbiota Transplantation as a Treatment for Ulcerative Colitis (NCT04434872) | Tel-Aviv Sourasky Medical Center | 2015-07-01 |
| Treatment of CIK for Patients With Refractory Non-Hodgkin Lymphoma (NCT02497898) | The First People's Hospital of Changzhou | 2015-07-01 |
| Administration of Expanded Autologous Adult Bone Marrow Mesenchymal Cells in Established Chronic Spinal Cord Injuries (NCT02570932) | Puerta de Hierro University Hospital | 2015-07-01 |
| A Study of UCB0942 in Adult Patients With Highly Drug-resistant Focal Epilepsy (NCT02495844) | UCB Biopharma S.P.R.L. | 2015-07-01 |
| Bio-availability of Rectal Artesunate in Children With Severe Falciparum Malaria (NCT02492178) | University of Oxford | 2015-07-01 |
| A Single-blind Pilot Study to Investigate Safety and Tolerability of the Chymase Inhibitor BAY1142524 in Clinically Stable Patients With Left-ventricular Dysfunction (NCT02452515) | Bayer | 2015-07-01 |
| A Phase II Study to Evaluate Safety and Efficacy of ALX-0061 in Subjects With Systemic Lupus Erythematosus (NCT02437890) | Ablynx, a Sanofi company | 2015-07-01 |
| OTO-201 for the Treatment of Otitis Externa (NCT02511561) | Otonomy, Inc. | 2015-07-01 |
| Selepressin Evaluation Programme for Sepsis-Induced Shock - Adaptive Clinical Trial (NCT02508649) | Ferring Pharmaceuticals | 2015-07-01 |
| Urelumab (CD137 mAb) With Rituximab for Relapsed, Refractory or High-risk Untreated Chronic Lymphocytic Leukemia (CLL) Patients (NCT02420938) | M.D. Anderson Cancer Center | 2015-07-01 |
| Metformin in Combination With Standard Induction Therapy for Large B-cell Lymphoma (DLBCL) (NCT02531308) | Rush University Medical Center | 2015-07-01 |
| Reactivating NK Cells in Treating Refractory Head and Neck Cancer (NCT02507154) | National University Hospital, Singapore | 2015-07-01 |
| Clinical Trial to Evaluate Efficacy and Safety of JOINTSTEM in Patients With Degenerative Arthritis (NCT02658344) | R-Bio | 2015-07-01 |
| eIMPACT Trial: Modernized Collaborative Care to Reduce the Excess CVD Risk of Older Depressed Patients (NCT02458690) | Indiana University | 2015-07-01 |
| Lung Recruitment and Postoperative CPAP (NCT02502279) | Assiut University | 2015-07-01 |
| Trabectedin for Recurrent Grade II/III Meningioma (NCT02234050) | European Organisation for Research and Treatment of Cancer - EORTC | 2015-07-01 |
| Safety Study of Eteplirsen to Treat Early Stage Duchenne Muscular Dystrophy (NCT02420379) | Sarepta Therapeutics, Inc. | 2015-06-30 |
| Essentiality of INH in TB Therapy (NCT01589497) | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 2015-06-30 |
| Clinical Trial to Evaluate the Efficacy of Vemurafenib in Combination With Cobimetinib (Continuous and Intermittent) in BRAFV600-mutation Positive Patients With Unresectable Locally Advanced or Metastatic Melanoma (NCT02583516) | Grupo Español Multidisciplinar de Melanoma | 2015-06-30 |
| A Randomised Trial of Imatinib Alternating With Regorafenib Compared to Imatinib Alone for the First Line Treatment of Advanced Gastrointestinal Stromal Tumour (GIST) (NCT02365441) | Australasian Gastro-Intestinal Trials Group | 2015-06-30 |
| A Study to Evaluate 4-year Antibody Persistence and Booster Response Following MenABCWY Vaccination in Healthy Adolescents and Young Adults Who Previously Participated in Studies V102_02 (NCT01210885) and V102_02E1 (NCT01367158) (NCT02451514) | GlaxoSmithKline | 2015-06-30 |
| Blinatumomab and Combination Chemotherapy or Dasatinib, Prednisone, and Blinatumomab in Treating Older Patients With Acute Lymphoblastic Leukemia (NCT02143414) | National Cancer Institute (NCI) | 2015-06-30 |
| Phase II Study of Refametinib, a MEK Inhibitor, as Second-line Treatment in Advanced Biliary Tract Adenocarcinoma (NCT02346032) | Samsung Medical Center | 2015-06-30 |
| Nintedanib Compared With Placebo in Treating Against Radiation-Induced Pneumonitis in Patients With Non-small Cell Lung Cancer That Cannot Be Removed by Surgery and Are Undergoing Chemoradiation Therapy (NCT02452463) | Roswell Park Cancer Institute | 2015-06-29 |
| Treatment of Familiar Lymphohistiocytosis (NCT02472054) | Assistance Publique - Hôpitaux de Paris | 2015-06-29 |
| A Comparative Phase 2 Study Assessing the Efficacy of Triheptanoin, an Anaplerotic Therapy in Huntington's Disease (NCT02453061) | Institut National de la Santé Et de la Recherche Médicale, France | 2015-06-29 |
| Phase I/II Study of the Anti-Programmed Death Ligand-1 Durvalumab Antibody (MEDI4736) in Combination With Olaparib and/or Cediranib for Advanced Solid Tumors and Advanced or Recurrent Ovarian, Triple Negative Breast, Lung, Prostate and Colorectal Can... (NCT02484404) | National Cancer Institute (NCI) | 2015-06-29 |
| Prolonged Release Pirfenidone Versus Placebo in Compensated Cirrhosis. (NCT06267794) | Jorge L Poo | 2015-06-26 |
| Phase II Study of Abraxane and Gemicitabine in Patients With Advanced Adenocarcinoma Non-Small Cell Lung Cancer Progressing After First-Line Platinum-Based Chemotherapy (NCT02303977) | Abramson Cancer Center at Penn Medicine | 2015-06-26 |
| A Study of AG-348 in Adult Participants With Pyruvate Kinase (PK) Deficiency (NCT02476916) | Agios Pharmaceuticals, Inc. | 2015-06-26 |
| Trilaciclib (G1T28), a CDK 4/6 Inhibitor, in Combination With Etoposide and Carboplatin in Extensive Stage Small Cell Lung Cancer (SCLC) (NCT02499770) | G1 Therapeutics, Inc. | 2015-06-26 |
| A Phase II Clinical Trial of Hydronidone Capsules(F351) in Patients With Liver Fibrosis Induced by HBV Chronic Hepatitis (NCT02499562) | Shanghai Genomics, Inc. | 2015-06-25 |
| A Study of ASP8273 in Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor-Naïve Patients With Non-Small Cell Lung Cancer Harboring EGFR Mutations (NCT02500927) | Astellas Pharma Inc | 2015-06-25 |
| Prospective Translational Study Investigating Possible Molecular prEdictors of Resistance to First-Line pazopanIb (NCT04462445) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2015-06-25 |
| A Multiple Dosing (14 Days) Study to Assess Efficacy and Safety of Three Dose Levels of AZD7594, Given Once Daily by Inhalation, in Patients With Mild to Moderate Asthma (NCT02479412) | AstraZeneca | 2015-06-25 |
| Research Examining Gulf War Illness in Our Nations Service Members (NCT01846182) | VA Office of Research and Development | 2015-06-24 |
| Safety and Immunogenicity of Norovirus GI.1/GII.4 Bivalent Virus-Like Particle (VLP) Vaccine in Children (NCT02153112) | Takeda | 2015-06-23 |
| Nab-paclitaxel and Gemcitabine, in Elderly Patients Untreated Metastatic Pancreatic Adenocarcinoma (NCT02391662) | Asociación de Oncología Médica del Hospital de Cruces | 2015-06-23 |
| Efficacy and Safety of BI 655066/ABBV-066 (Risankizumab) in Patients With Severe Persistent Asthma (NCT02443298) | AbbVie | 2015-06-23 |
| Lirilumab With Rituximab for Relapsed, Refractory or High-risk Untreated Chronic Lymphocytic Leukemia (CLL) Patients (NCT02481297) | M.D. Anderson Cancer Center | 2015-06-23 |
| Minocycline Hydrochloride in Reducing Chemotherapy Induced Depression and Anxiety in Patients With Stage I-III Breast Cancer (NCT02203552) | Ohio State University Comprehensive Cancer Center | 2015-06-23 |
| Metformin Hydrochloride and Aspirin in Treating Patients With Hormone-Dependent Prostate Cancer That Has Progressed After Surgery or Radiation Therapy (NCT02420652) | Rutgers, The State University of New Jersey | 2015-06-23 |
| Pazopanib Maintenance Phase II (NCT02207309) | Ludwig-Maximilians - University of Munich | 2015-06-22 |
| To Investigate the Pharmacological Effects, Drug Blood Levels and Safety of an Intrauterine System Releasing the Study Drug BAY1007626 in Comparison to Mirena and Jaydess in Healthy Young Women Treated for 90 Days to Determine the Drug Dose for Further Development (NCT02490774) | Bayer | 2015-06-22 |
| Follow-up Study to Investigate the Effect of GSK2245035 on Nasal Allergic Reactivity in Subjects Completing Treatment in Study TL7116958 (NCT02446613) | GlaxoSmithKline | 2015-06-22 |
| Phase II Single Arm Study of AZD9291 to Treat NSCLC Patients in Asia Pacific (NCT02442349) | AstraZeneca | 2015-06-22 |
| Nintedanib For HER2-Negative Metastatic Inflammatory Breast Cancer (MIBC) (NCT02389764) | M.D. Anderson Cancer Center | 2015-06-22 |
| A Study to Assess Resistance and Durability of Response to ABT-493 and/or ABT-530 (NCT02441283) | AbbVie | 2015-06-22 |
| Sorafenib for Prophylaxis of Leukemia Relapse in Allo-HSCT Recipients With FLT3-ITD Positive AML (NCT02474290) | Nanfang Hospital, Southern Medical University | 2015-06-20 |
| Study of BMS-986158 in Subjects With Select Advanced Cancers (NCT02419417) | Bristol-Myers Squibb | 2015-06-19 |
| Nivolumab and Ibrutinib in Treating Patients With Relapsed, Refractory, or High-Risk Untreated Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Richter Transformation (NCT02420912) | M.D. Anderson Cancer Center | 2015-06-19 |
| A Study of BMS-986148 in Patients With Select Advanced Solid Tumors (NCT02341625) | Bristol-Myers Squibb | 2015-06-19 |
| Role of PPAR-y Agonists in Immunomodulation and Vascular Prevention in SLE (PPAR-SLE) (NCT02338999) | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | 2015-06-18 |
| Effects of Bronchial Segmental Endotoxin Instillation in Humans (NCT02392442) | National Institutes of Health Clinical Center (CC) | 2015-06-18 |
| Cabazitaxel Versus the Switch to Alternative AR Targeted Therapy Enzalutamide or Abiraterone in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Primary Resistant Patients to Abiraterone or Enzalutamide (NCT02379390) | Sanofi | 2015-06-17 |
| Safety and Efficacy of LAG525 Single Agent and in Combination With PDR001 in Patients With Advanced Malignancies. (NCT02460224) | Novartis Pharmaceuticals | 2015-06-17 |
| Carfilzomib/Cyclophosphamide/Dexamethasone with Maintenance Carfilzomib in Multiple Myeloma (NCT02315716) | University College, London | 2015-06-16 |
| Study to Evaluate the Efficacy and Safety of Eribulin Mesylate Administered Biweekly (Q2W) for Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Metastatic Breast Cancer (NCT02481050) | Eisai Inc. | 2015-06-16 |
| Capnometry-Assisted Breathing Training for COPD (NCT03457103) | NYU Langone Health | 2015-06-16 |
| 18F-FSPG PET/CT in Imaging Patients With Newly Diagnosed Lung Cancer or Indeterminate Pulmonary Nodules (NCT02448225) | Vanderbilt-Ingram Cancer Center | 2015-06-16 |
| Study of CLAG + Selinexor in Relapsed or Refractory Acute Myeloid Leukemia (NCT02416908) | Washington University School of Medicine | 2015-06-16 |
| A Study of Accelerated 3 Fraction Photon,Proton or Brachytherapy for Early Invasive and Noninvasive Breast Ca (NCT02453737) | Mayo Clinic | 2015-06-16 |
| Comparison of an Artificial Pancreas Versus Threshold Low Glucose Suspend in Type 1 Diabetic Children (NCT02509429) | University Hospital, Montpellier | 2015-06-16 |
| Ides in Highly Sensitized (HS) Patients Awaiting Kidney Transplantation (NCT02426684) | Cedars-Sinai Medical Center | 2015-06-16 |
| Adenomyosis and Ulipristal Acetate (NCT02587000) | Assistance Publique - Hôpitaux de Paris | 2015-06-16 |
| Comparison of the Efficacy of Calcium Hydroxide With Silver Nanoparticle and Conventional Calcium Hydroxide Intra Canal Medications on Post-Operative Pain in Symptomatic Root Canal Treatment Failure Cases: (NCT04213716) | Cairo University | 2015-06-15 |
| Phase 2a Study of BAX69 and 5-FU/Leucovorin or Panitumumab Versus Standard of Care in Subjects With Metastatic Colorectal Cancer (NCT02448810) | Baxalta now part of Shire | 2015-06-15 |
| Paclitaxel/Pazopanib for Platinum Resistant/Refractory Ovarian Cancer (NCT02383251) | ARCAGY/ GINECO GROUP | 2015-06-15 |
| A Study to Assess Safety, Tolerability, and Immunogenicity of Three Heterologus 2-dose Regimens of the Candidate Prophylactic Vaccines for Ebola in Healthy Adults (NCT02416453) | Janssen Vaccines & Prevention B.V. | 2015-06-15 |
| Pacritinib Before Transplant for Myeloproliferative Neoplasms (MPN) (NCT02410551) | M.D. Anderson Cancer Center | 2015-06-15 |
| Pacritinib Combined With Decitabine or Cytarabine in Older Patients With AML (NCT02532010) | Weill Medical College of Cornell University | 2015-06-15 |
| A Study Investigating the Effect of Digesta-Lac in Healthy Adults With Occasional Constipation (NCT02423564) | KGK Science Inc. | 2015-06-12 |
| Topical NVN1000 for the Treatment of External Genital and Perianal Warts (NCT02462187) | Novan, Inc. | 2015-06-12 |
| ART-2 Pilot - Driving Pressure Limited Ventilation for Patients With ARDS (NCT02365038) | Hospital do Coracao | 2015-06-12 |
| Integrated Imaging Strategy to Phenotype Progression of Liver Tumors During and After Chemoembolization (NCT02471313) | National Institutes of Health Clinical Center (CC) | 2015-06-12 |
| Romidepsin and Lenalidomide in Treating Patients With Previously Untreated Peripheral T-Cell Lymphoma (NCT02232516) | Northwestern University | 2015-06-11 |
| Tipepidine in Children With Attention Deficit/Hyperactivity Disorder (AD/HD): a Double-blind, Placebo-controlled Trial (NCT02305134) | Chiba University | 2015-06-11 |
| Study of Pembrolizumab (MK-3475) Monotherapy for Metastatic Triple-Negative Breast Cancer (MK-3475-086/KEYNOTE-086) (NCT02447003) | Merck Sharp & Dohme LLC | 2015-06-11 |
| Pembrolizumab in Treating Patients With Stage IV Metastatic or Recurrent Inflammatory Breast Cancer or Triple-Negative Breast Cancer Who Have Achieved Clinical Response or Stable Disease to Prior Chemotherapy (NCT02411656) | M.D. Anderson Cancer Center | 2015-06-11 |
| Study of Oral cMET Inhibitor INC280 in Patients With EGFR Wild-type (wt), Advanced Non-small Cell Lung Cancer (NSCLC) (Geometry Mono-1) (NCT02414139) | Novartis Pharmaceuticals | 2015-06-11 |
| Efficacy and Safety of a Botanical Total Coumarin (TC) Cream in Treating Patients With Psoriasis Vulgaris (PLANTCOAT-IIb Trial) (NCT03372811) | Psoriasis Research Institute of Guangzhou | 2015-06-11 |
| A Safety and Efficacy Study of JNJ-42165279 in Participants With Social Anxiety Disorder (NCT02432703) | Janssen Research & Development, LLC | 2015-06-11 |
| Lenalidomide in Improving Immune Response to Vaccine Therapy in Patients With Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Monoclonal B Cell Lymphocytosis (NCT02309515) | Mayo Clinic | 2015-06-11 |
| Buccal Versus Intranasal Route of Administration of Midazolam Spray in Behavior Management of Pre-School Patients (NCT04608734) | Nourhan M.Aly | 2015-06-10 |
| Trial of AAV5-hFIX in Severe or Moderately Severe Hemophilia B (NCT02396342) | CSL Behring | 2015-06-10 |
| Indocyanine Green for Central Nervous System Tumors (NCT02710240) | Abramson Cancer Center at Penn Medicine | 2015-06-10 |
| Study of Pembrolizumab (MK-3475) in Participants With Relapsed or Refractory Classical Hodgkin Lymphoma (MK-3475-087/KEYNOTE-087) (NCT02453594) | Merck Sharp & Dohme LLC | 2015-06-10 |
| Viral Kinetics, Interferon Stimulated Genes (ISGs) and mirRNA Among Subjects Infected With Different Hepatitis C Virus Genotypes During Therapy With Sofosbuvir and GS-5816 (NCT02468648) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2015-06-09 |
| A Phase 2a, Randomized, Placebo Controlled, Study to Evaluate the Safety and Efficacy of AMG 557/MEDI5872 in Primary Sjögren's Syndrome (NCT02334306) | MedImmune LLC | 2015-06-08 |
| Hypofractionated Boost Before Chemoradiation for Patients With Stage II-III Non-small Cell Lung Cancer Unsuitable for Surgery (NCT02262325) | Ohio State University Comprehensive Cancer Center | 2015-06-08 |
| Safety, Tolerability, and Efficacy of GS-4997 Alone or in Combination With Simtuzumab (SIM) in Adults With Nonalcoholic Steatohepatitis (NASH) and Fibrosis Stages F2-F3 (NCT02466516) | Gilead Sciences | 2015-06-08 |
| Study of LY2228820 With Radiotherapy Plus Concomitant TMZ in the Treatment of Newly Diagnosed Glioblastoma (NCT02364206) | Centre Jean Perrin | 2015-06-08 |
| Interest of Pregabalin (Lyrica) on the Treatment of Reflex Earache in Head and Neck Cancer. (NCT02924675) | University Hospital, Lille | 2015-06-05 |
| Two Dose Levels of DFN-15 vs. Placebo in Patients With Migraine Headaches (NCT02472418) | Dr. Reddy's Laboratories Limited | 2015-06-05 |
| Vincristine Sulfate Liposome in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia (NCT02337478) | Wake Forest University Health Sciences | 2015-06-05 |
| AML-02: Omacetaxine With Standard-of-Care Induction With Cytarabine & Idarubicin in Newly-Diagnosed AML Patients (NCT02440568) | University of Illinois at Chicago | 2015-06-05 |